Skleroderma (Turkish Wikipedia)
Analysis of information sources in references of the Wikipedia article "Skleroderma" in Turkish language version.
refsWebsite
Global rank
Turkish rank
1st place
1st place
719th place
582nd place
6th place
6th place
3rd place
5th place
11th place
589th place
5,181st place
5,723rd place
287th place
193rd place
3,097th place
3,478th place
18th place
47th place
archive.org (Global: 6th place; Turkish: 6th place)
- Jameson, Larry (2018). "Chapter 353". Harrison's Principles of Internal Medicine (20. bas.). McGraw Hill.
- Elston, William D. James, Timothy G. Berger, Dirk M. (2006). Andrew's diseases of the skin: clinical dermatology (10 bas.). Philadelphia, PA: Saunders Elsevier. ss. 169-172. ISBN 978-0808923510.
- Brunton, L; Chabner, B; Knollman, B (2010). Goodman and Gilman's The Pharmacological Basis of Therapeutics (12. bas.). New York: McGraw-Hill Professional. ISBN 978-0-07-162442-8.[sayfa belirt]
books.google.com (Global: 3rd place; Turkish: 5th place)
- Unsal, Erbil (2006). Current Opinions in Pediatric Rheumatology (İngilizce). Nova Publishers. s. 302. ISBN 9781594548710. 6 Eylül 2017 tarihinde kaynağından arşivlendi.
- Mackay, Ian R.; Rose, Noel R. (2006). The Autoimmune Diseases (İngilizce). Academic Press. s. 369. ISBN 9780080454740. 29 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Temmuz 2022.
- Firestein, Gary S.; Kelley, William N.; Budd, Ralph C. (2012). Kelley's Textbook of Rheumatology (İngilizce). Elsevier Health Sciences. s. 1366. ISBN 978-1437717389. 4 Ağustos 2017 tarihinde kaynağından arşivlendi.
doi.org (Global: 2nd place; Turkish: 4th place)
- Barnes J, Mayes MD (March 2012). "Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers". Current Opinion in Rheumatology. 24 (2): 165-70. doi:10.1097/BOR.0b013e32834ff2e8. PMID 22269658. 29 Ağustos 2021 tarihinde kaynağından arşivlendi5 Temmuz 2022.
- Greenblatt MB, Aliprantis AO (January 2013). "The immune pathogenesis of scleroderma: context is everything". Current Rheumatology Reports. 15 (1): 297. doi:10.1007/s11926-012-0297-8. PMC 3539168 $2. PMID 23288576.
- Denton, Christopher P; Khanna, Dinesh (October 2017). "Systemic sclerosis". The Lancet. 390 (10103): 1685-99. doi:10.1016/s0140-6736(17)30933-9. PMID 28413064.
- Balbir-Gurman A, Braun-Moscovici Y (February 2012). "Scleroderma – new aspects in pathogenesis and treatment". Best Practice & Research. Clinical Rheumatology. 26 (1): 13-24. doi:10.1016/j.berh.2012.01.011. PMID 22424190.
- Dospinescu P, Jones GT, Basu N (March 2013). "Environmental risk factors in systemic sclerosis". Current Opinion in Rheumatology. 25 (2): 179-83. doi:10.1097/BOR.0b013e32835cfc2d. PMID 23287382.
- Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (February 2014). "Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature". Autoimmunity Reviews. 13 (2): 151-56. doi:10.1016/j.autrev.2013.10.002. PMID 24129037.
- Walker KM, Pope J (August 2012). "Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts". Seminars in Arthritis and Rheumatism. 42 (1): 42-55. doi:10.1016/j.semarthrit.2012.01.003. PMID 22464314.
- Fett N (July–August 2013). "Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies". Clinics in Dermatology. 31 (4): 432-37. doi:10.1016/j.clindermatol.2013.01.010. PMID 23806160.
- Shah AA, Wigley FM (April 2013). "My approach to the treatment of scleroderma". Mayo Clinic Proceedings. 88 (4): 377-93. doi:10.1016/j.mayocp.2013.01.018. PMC 3666163 $2. PMID 23541012.
- Beyer C, Dees C, Distler JH (January 2013). "Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis". Archives of Dermatological Research. 305 (1): 1-8. doi:10.1007/s00403-012-1304-7. PMID 23208311.
- Leask A (June 2012). "Emerging targets for the treatment of scleroderma". Expert Opinion on Emerging Drugs. 17 (2): 173-79. doi:10.1517/14728214.2012.678833. PMID 22533795.
- Manno R, Boin F (November 2010). "Immunotherapy of systemic sclerosis". Immunotherapy. 2 (6): 863-78. doi:10.2217/imt.10.69. PMC 3059511 $2. PMID 21091117.
- Postlethwaite AE, Harris LJ, Raza SH, Kodura S, Akhigbe T (April 2010). "Pharmacotherapy of systemic sclerosis". Expert Opinion on Pharmacotherapy. 11 (5): 789-806. doi:10.1517/14656561003592177. PMC 2837533 $2. PMID 20210685.
- Ong VH, Denton CP (May 2010). "Innovative therapies for systemic sclerosis". Current Opinion in Rheumatology. 22 (3): 264-72. doi:10.1097/BOR.0b013e328337c3d6. PMID 20190640.
- Valančienė G, Jasaitienė D, Valiukevičienė S (2010). "Pathogenesis and treatment modalities of localized scleroderma" (PDF). Medicina. 46 (10): 649-56. doi:10.3390/medicina46100092
. PMID 21393982. 6 Mart 2014 tarihinde kaynağından arşivlendi (PDF). - Katsumoto TR, Whitfield ML, Connolly MK (2011). "The pathogenesis of systemic sclerosis". Annual Review of Pathology. 6: 509-37. doi:10.1146/annurev-pathol-011110-130312. PMID 21090968.
- Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R (August 2011). "Angiogenic cytokines and growth factors in systemic sclerosis". Autoimmunity Reviews. 10 (10): 590-94. doi:10.1016/j.autrev.2011.04.019. PMID 21549861.
- Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R (August 2011). "Cellular players in angiogenesis during the course of systemic sclerosis". Autoimmunity Reviews. 10 (10): 641-46. doi:10.1016/j.autrev.2011.04.016. PMID 21549220.
- Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, Ferraccioli G (August 2011). "B cells in systemic sclerosis: a possible target for therapy". Autoimmunity Reviews. 10 (10): 624-30. doi:10.1016/j.autrev.2011.04.013. PMID 21545850.
- Hunzelmann N, Krieg T (May 2010). "Scleroderma: from pathophysiology to novel therapeutic approaches". Experimental Dermatology. 19 (5): 393-400. doi:10.1111/j.1600-0625.2010.01082.x. PMID 20507361.
- Leask A (June 2011). "The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis". Pharmacological Research. 63 (6): 502-03. doi:10.1016/j.phrs.2011.01.011. PMID 21315153.
- Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Castañón M, López-Hoyos M, Matucci-Cerinic M, Szücs G, Shapira Y, Szekanecz Z, Shoenfeld Y (June 2011). "Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature". Autoimmunity Reviews. 10 (8): 490-94. doi:10.1016/j.autrev.2011.02.002. PMID 21320645.
- Alenghat FJ (February 2016). "The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors". Scientific Reports. 6: 20303. Bibcode:2016NatSR...620303A. doi:10.1038/srep20303. PMC 4740809 $2. PMID 26842423.
- Ngian GS, Sahhar J, Wicks IP, Van Doornum S (August 2011). "Cardiovascular disease in systemic sclerosis--an emerging association?". Arthritis Research & Therapy. 13 (4): 237. doi:10.1186/ar3445. PMC 3239376 $2. PMID 21888685.
- Szekanecz É, Szamosi S, Horváth Á, Németh Á, Juhász B, Szántó J, Szücs G, Szekanecz Z (October 2012). "Malignancies associated with systemic sclerosis". Autoimmunity Reviews. 11 (12): 852-55. doi:10.1016/j.autrev.2012.02.021. PMID 22410174.
- Shah AA, Rosen A (November 2011). "Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications". Current Opinion in Rheumatology. 23 (6): 530-35. doi:10.1097/BOR.0b013e32834a5081. PMC 3373179 $2. PMID 21825998.
- Onishi A, Sugiyama D, Kumagai S, Morinobu A (July 2013). "Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies". Arthritis and Rheumatism. 65 (7): 1913-21. doi:10.1002/art.37969 . PMID 23576072.
- Bonifazi M, Tramacere I, Pomponio G, Gabrielli B, Avvedimento EV, La Vecchia C, Negri E, Gabrielli A (January 2013). "Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies". Rheumatology. 52 (1): 143-54. doi:10.1093/rheumatology/kes303 . PMID 23175568.
- Kennedy N, Walker J, Hakendorf P, Roberts-Thomson P (23 Mart 2018). "Improving life expectancy of patients with scleroderma: results from the South Australian Scleroderma Register". Internal Medicine Journal. 48 (8): 951-56. doi:10.1111/imj.13799. PMID 29573101.
- Sticherling M (October 2012). "Systemic sclerosis-dermatological aspects. Part 1: Pathogenesis, epidemiology, clinical findings". Journal der Deutschen Dermatologischen Gesellschaft. 10 (10): 705-18; quiz 716. doi:10.1111/j.1610-0387.2012.07999.x . PMID 22913330.
- Nikpour M, Stevens WM, Herrick AL, Proudman SM (December 2010). "Epidemiology of systemic sclerosis". Best Practice & Research. Clinical Rheumatology. 24 (6): 857-69. doi:10.1016/j.berh.2010.10.007. PMID 21665131.
- Gelber AC, Manno RL, Shah AA, Woods A, Le EN, Boin F, Hummers LK, Wigley FM (July 2013). "Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature". Medicine. 92 (4): 191-205. doi:10.1097/MD.0b013e31829be125. PMC 4553970 $2. PMID 23793108.
- Lidar M, Langevitz P (May 2012). "Pregnancy issues in scleroderma". Autoimmunity Reviews. 11 (6–7): A515-19. doi:10.1016/j.autrev.2011.11.021. PMID 22155199.
etymonline.com (Global: 287th place; Turkish: 193rd place)
- Harper, Douglas. "scleroderma". Online Etymology Dictionary.
harvard.edu (Global: 18th place; Turkish: 47th place)
adsabs.harvard.edu
- Alenghat FJ (February 2016). "The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors". Scientific Reports. 6: 20303. Bibcode:2016NatSR...620303A. doi:10.1038/srep20303. PMC 4740809 $2. PMID 26842423.
kmu.lt (Global: low place; Turkish: low place)
medicina.kmu.lt
- Valančienė G, Jasaitienė D, Valiukevičienė S (2010). "Pathogenesis and treatment modalities of localized scleroderma" (PDF). Medicina. 46 (10): 649-56. doi:10.3390/medicina46100092 . PMID 21393982. 6 Mart 2014 tarihinde kaynağından arşivlendi (PDF).
medscape.com (Global: 719th place; Turkish: 582nd place)
emedicine.medscape.com
- Jimenez, SA; Cronin, PM; Koenig, AS; O'Brien, MS; Castro, SV (15 Şubat 2012). Varga, J; Talavera, F; Goldberg, E; Mechaber, AJ; Diamond, HS (Ed.). "Scleroderma Clinical Presentation". Medscape Reference. WebMD. 6 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2014.
- Jimenez, SA; Cronin, PM; Koenig, AS; O'Brien, MS; Castro, SV (15 Şubat 2012). Varga, J; Talavera, F; Goldberg, E; Mechaber, AJ; Diamond, HS (Ed.). "Scleroderma Workup". Medscape Reference. WebMD. 6 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Mart 2014.
- Jimenez, SA; Cronin, PM; Koenig, AS; O'Brien, MS; Castro, SV (15 Şubat 2012). Varga, J; Talavera, F; Goldberg, E; Mechaber, AJ; Diamond, HS (Ed.). "Scleroderma Differential Diagnoses". Medscape Reference. WebMD. 6 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Mart 2014.
reference.medscape.com
- "Medscape Multispecialty – Home page". WebMD. 13 Kasım 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Kasım 2013.[tam kaynak belirtilmeli]
merckmanuals.com (Global: 3,097th place; Turkish: 3,478th place)
- Hajj-ali, RA (June 2013). "Systemic Sclerosis". Merck Manual Professional. Merck Sharp & Dohme Corp. 6 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2014.
nih.gov (Global: 4th place; Turkish: 11th place)
ncbi.nlm.nih.gov
- Barnes J, Mayes MD (March 2012). "Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers". Current Opinion in Rheumatology. 24 (2): 165-70. doi:10.1097/BOR.0b013e32834ff2e8. PMID 22269658. 29 Ağustos 2021 tarihinde kaynağından arşivlendi5 Temmuz 2022.
- Greenblatt MB, Aliprantis AO (January 2013). "The immune pathogenesis of scleroderma: context is everything". Current Rheumatology Reports. 15 (1): 297. doi:10.1007/s11926-012-0297-8. PMC 3539168 $2. PMID 23288576.
- Denton, Christopher P; Khanna, Dinesh (October 2017). "Systemic sclerosis". The Lancet. 390 (10103): 1685-99. doi:10.1016/s0140-6736(17)30933-9. PMID 28413064.
- Balbir-Gurman A, Braun-Moscovici Y (February 2012). "Scleroderma – new aspects in pathogenesis and treatment". Best Practice & Research. Clinical Rheumatology. 26 (1): 13-24. doi:10.1016/j.berh.2012.01.011. PMID 22424190.
- Dospinescu P, Jones GT, Basu N (March 2013). "Environmental risk factors in systemic sclerosis". Current Opinion in Rheumatology. 25 (2): 179-83. doi:10.1097/BOR.0b013e32835cfc2d. PMID 23287382.
- Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (February 2014). "Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature". Autoimmunity Reviews. 13 (2): 151-56. doi:10.1016/j.autrev.2013.10.002. PMID 24129037.
- Walker KM, Pope J (August 2012). "Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts". Seminars in Arthritis and Rheumatism. 42 (1): 42-55. doi:10.1016/j.semarthrit.2012.01.003. PMID 22464314.
- Fett N (July–August 2013). "Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies". Clinics in Dermatology. 31 (4): 432-37. doi:10.1016/j.clindermatol.2013.01.010. PMID 23806160.
- Shah AA, Wigley FM (April 2013). "My approach to the treatment of scleroderma". Mayo Clinic Proceedings. 88 (4): 377-93. doi:10.1016/j.mayocp.2013.01.018. PMC 3666163 $2. PMID 23541012.
- Kowal-Bielecka O, Bielecki M, Kowal K (2013). "Recent advances in the diagnosis and treatment of systemic sclerosis" (PDF). Polskie Archiwum Medycyny Wewnetrznej. 123 (1–2): 51-58. PMID 23344666. 6 Mart 2014 tarihinde kaynağından arşivlendi (PDF).
- Beyer C, Dees C, Distler JH (January 2013). "Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis". Archives of Dermatological Research. 305 (1): 1-8. doi:10.1007/s00403-012-1304-7. PMID 23208311.
- Leask A (June 2012). "Emerging targets for the treatment of scleroderma". Expert Opinion on Emerging Drugs. 17 (2): 173-79. doi:10.1517/14728214.2012.678833. PMID 22533795.
- Manno R, Boin F (November 2010). "Immunotherapy of systemic sclerosis". Immunotherapy. 2 (6): 863-78. doi:10.2217/imt.10.69. PMC 3059511 $2. PMID 21091117.
- Postlethwaite AE, Harris LJ, Raza SH, Kodura S, Akhigbe T (April 2010). "Pharmacotherapy of systemic sclerosis". Expert Opinion on Pharmacotherapy. 11 (5): 789-806. doi:10.1517/14656561003592177. PMC 2837533 $2. PMID 20210685.
- Ong VH, Denton CP (May 2010). "Innovative therapies for systemic sclerosis". Current Opinion in Rheumatology. 22 (3): 264-72. doi:10.1097/BOR.0b013e328337c3d6. PMID 20190640.
- Valančienė G, Jasaitienė D, Valiukevičienė S (2010). "Pathogenesis and treatment modalities of localized scleroderma" (PDF). Medicina. 46 (10): 649-56. doi:10.3390/medicina46100092 . PMID 21393982. 6 Mart 2014 tarihinde kaynağından arşivlendi (PDF).
- Katsumoto TR, Whitfield ML, Connolly MK (2011). "The pathogenesis of systemic sclerosis". Annual Review of Pathology. 6: 509-37. doi:10.1146/annurev-pathol-011110-130312. PMID 21090968.
- Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R (August 2011). "Angiogenic cytokines and growth factors in systemic sclerosis". Autoimmunity Reviews. 10 (10): 590-94. doi:10.1016/j.autrev.2011.04.019. PMID 21549861.
- Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R (August 2011). "Cellular players in angiogenesis during the course of systemic sclerosis". Autoimmunity Reviews. 10 (10): 641-46. doi:10.1016/j.autrev.2011.04.016. PMID 21549220.
- Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, Ferraccioli G (August 2011). "B cells in systemic sclerosis: a possible target for therapy". Autoimmunity Reviews. 10 (10): 624-30. doi:10.1016/j.autrev.2011.04.013. PMID 21545850.
- Hunzelmann N, Krieg T (May 2010). "Scleroderma: from pathophysiology to novel therapeutic approaches". Experimental Dermatology. 19 (5): 393-400. doi:10.1111/j.1600-0625.2010.01082.x. PMID 20507361.
- Leask A (June 2011). "The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis". Pharmacological Research. 63 (6): 502-03. doi:10.1016/j.phrs.2011.01.011. PMID 21315153.
- Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Castañón M, López-Hoyos M, Matucci-Cerinic M, Szücs G, Shapira Y, Szekanecz Z, Shoenfeld Y (June 2011). "Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature". Autoimmunity Reviews. 10 (8): 490-94. doi:10.1016/j.autrev.2011.02.002. PMID 21320645.
- Alenghat FJ (February 2016). "The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors". Scientific Reports. 6: 20303. Bibcode:2016NatSR...620303A. doi:10.1038/srep20303. PMC 4740809 $2. PMID 26842423.
- Ngian GS, Sahhar J, Wicks IP, Van Doornum S (August 2011). "Cardiovascular disease in systemic sclerosis--an emerging association?". Arthritis Research & Therapy. 13 (4): 237. doi:10.1186/ar3445. PMC 3239376 $2. PMID 21888685.
- Szekanecz É, Szamosi S, Horváth Á, Németh Á, Juhász B, Szántó J, Szücs G, Szekanecz Z (October 2012). "Malignancies associated with systemic sclerosis". Autoimmunity Reviews. 11 (12): 852-55. doi:10.1016/j.autrev.2012.02.021. PMID 22410174.
- Shah AA, Rosen A (November 2011). "Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications". Current Opinion in Rheumatology. 23 (6): 530-35. doi:10.1097/BOR.0b013e32834a5081. PMC 3373179 $2. PMID 21825998.
- Onishi A, Sugiyama D, Kumagai S, Morinobu A (July 2013). "Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies". Arthritis and Rheumatism. 65 (7): 1913-21. doi:10.1002/art.37969 . PMID 23576072.
- Bonifazi M, Tramacere I, Pomponio G, Gabrielli B, Avvedimento EV, La Vecchia C, Negri E, Gabrielli A (January 2013). "Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies". Rheumatology. 52 (1): 143-54. doi:10.1093/rheumatology/kes303 . PMID 23175568.
- Kennedy N, Walker J, Hakendorf P, Roberts-Thomson P (23 Mart 2018). "Improving life expectancy of patients with scleroderma: results from the South Australian Scleroderma Register". Internal Medicine Journal. 48 (8): 951-56. doi:10.1111/imj.13799. PMID 29573101.
- Sticherling M (October 2012). "Systemic sclerosis-dermatological aspects. Part 1: Pathogenesis, epidemiology, clinical findings". Journal der Deutschen Dermatologischen Gesellschaft. 10 (10): 705-18; quiz 716. doi:10.1111/j.1610-0387.2012.07999.x . PMID 22913330.
- Nikpour M, Stevens WM, Herrick AL, Proudman SM (December 2010). "Epidemiology of systemic sclerosis". Best Practice & Research. Clinical Rheumatology. 24 (6): 857-69. doi:10.1016/j.berh.2010.10.007. PMID 21665131.
- Gelber AC, Manno RL, Shah AA, Woods A, Le EN, Boin F, Hummers LK, Wigley FM (July 2013). "Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature". Medicine. 92 (4): 191-205. doi:10.1097/MD.0b013e31829be125. PMC 4553970 $2. PMID 23793108.
- Lidar M, Langevitz P (May 2012). "Pregnancy issues in scleroderma". Autoimmunity Reviews. 11 (6–7): A515-19. doi:10.1016/j.autrev.2011.11.021. PMID 22155199.
rarediseases.info.nih.gov
- "Scleroderma". GARD (İngilizce). 2017. 25 Ocak 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Temmuz 2017.
niams.nih.gov
- "Handout on Health: Scleroderma". NIAMS. August 2016. 4 Temmuz 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Temmuz 2017.
pamw.pl (Global: low place; Turkish: low place)
- Kowal-Bielecka O, Bielecki M, Kowal K (2013). "Recent advances in the diagnosis and treatment of systemic sclerosis" (PDF). Polskie Archiwum Medycyny Wewnetrznej. 123 (1–2): 51-58. PMID 23344666. 6 Mart 2014 tarihinde kaynağından arşivlendi (PDF).
rarediseases.org (Global: 5,181st place; Turkish: 5,723rd place)
- "Scleroderma". NORD (National Organization for Rare Disorders). 2007. 8 Eylül 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Temmuz 2017.
semanticscholar.org (Global: 11th place; Turkish: 589th place)
- Barnes J, Mayes MD (March 2012). "Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers". Current Opinion in Rheumatology. 24 (2): 165-70. doi:10.1097/BOR.0b013e32834ff2e8. PMID 22269658. 29 Ağustos 2021 tarihinde kaynağından arşivlendi5 Temmuz 2022.
tufts.edu (Global: 155th place; Turkish: 167th place)
perseus.tufts.edu
- Grekçe: σκληρός, Grekçe: δέρμα. Liddell, Henry George; Scott, Robert; A Greek–English Lexicon at the Perseus Project.
web.archive.org (Global: 1st place; Turkish: 1st place)
- "Scleroderma". GARD (İngilizce). 2017. 25 Ocak 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Temmuz 2017.
- Barnes J, Mayes MD (March 2012). "Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers". Current Opinion in Rheumatology. 24 (2): 165-70. doi:10.1097/BOR.0b013e32834ff2e8. PMID 22269658. 29 Ağustos 2021 tarihinde kaynağından arşivlendi5 Temmuz 2022.
- "Handout on Health: Scleroderma". NIAMS. August 2016. 4 Temmuz 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Temmuz 2017.
- "Scleroderma". NORD (National Organization for Rare Disorders). 2007. 8 Eylül 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Temmuz 2017.
- Unsal, Erbil (2006). Current Opinions in Pediatric Rheumatology (İngilizce). Nova Publishers. s. 302. ISBN 9781594548710. 6 Eylül 2017 tarihinde kaynağından arşivlendi.
- Mackay, Ian R.; Rose, Noel R. (2006). The Autoimmune Diseases (İngilizce). Academic Press. s. 369. ISBN 9780080454740. 29 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Temmuz 2022.
- Firestein, Gary S.; Kelley, William N.; Budd, Ralph C. (2012). Kelley's Textbook of Rheumatology (İngilizce). Elsevier Health Sciences. s. 1366. ISBN 978-1437717389. 4 Ağustos 2017 tarihinde kaynağından arşivlendi.
- Hajj-ali, RA (June 2013). "Systemic Sclerosis". Merck Manual Professional. Merck Sharp & Dohme Corp. 6 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2014.
- Jimenez, SA; Cronin, PM; Koenig, AS; O'Brien, MS; Castro, SV (15 Şubat 2012). Varga, J; Talavera, F; Goldberg, E; Mechaber, AJ; Diamond, HS (Ed.). "Scleroderma Clinical Presentation". Medscape Reference. WebMD. 6 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2014.
- Jimenez, SA; Cronin, PM; Koenig, AS; O'Brien, MS; Castro, SV (15 Şubat 2012). Varga, J; Talavera, F; Goldberg, E; Mechaber, AJ; Diamond, HS (Ed.). "Scleroderma Workup". Medscape Reference. WebMD. 6 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Mart 2014.
- Jimenez, SA; Cronin, PM; Koenig, AS; O'Brien, MS; Castro, SV (15 Şubat 2012). Varga, J; Talavera, F; Goldberg, E; Mechaber, AJ; Diamond, HS (Ed.). "Scleroderma Differential Diagnoses". Medscape Reference. WebMD. 6 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Mart 2014.
- Kowal-Bielecka O, Bielecki M, Kowal K (2013). "Recent advances in the diagnosis and treatment of systemic sclerosis" (PDF). Polskie Archiwum Medycyny Wewnetrznej. 123 (1–2): 51-58. PMID 23344666. 6 Mart 2014 tarihinde kaynağından arşivlendi (PDF).
- "Medscape Multispecialty – Home page". WebMD. 13 Kasım 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Kasım 2013.[tam kaynak belirtilmeli]
- Valančienė G, Jasaitienė D, Valiukevičienė S (2010). "Pathogenesis and treatment modalities of localized scleroderma" (PDF). Medicina. 46 (10): 649-56. doi:10.3390/medicina46100092 . PMID 21393982. 6 Mart 2014 tarihinde kaynağından arşivlendi (PDF).